Helixomer
Pre-clinicalHelixomer is a preclinical drug design and development powerhouse providing highly effective nanodrugs to healthcare heroes addressing some of the most difficult unmet healthcare needs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.8M
About
Helixomer is a preclinical drug design and development powerhouse providing highly effective nanodrugs to healthcare heroes addressing some of the most difficult unmet healthcare needs.
Small Molecules
Funding History
1Total raised:$2.8M
Seed$2.8MJan 15, 2022